ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in Montréal, QC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Infections
Coronavirus Infections
Human Influenza
Communicable Diseases
Post-Acute COVID-19 Syndrome
Pneumonia
Syndrome

COVID-19 trials near Montréal, QC, CAN:

Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial (CATCO)

This study is an adaptive, randomized, open-label, controlled clinical trial, in collaboration with countries around the world through the World Heal...

Active, not recruiting
COVID-19
Drug: Imatinib
Drug: Artesunate

Phase 3

Sunnybrook Health Sciences Centre

Montréal, Quebec, Canada and 52 other locations

The purpose of this study (Part 1 and Part 2) is to evaluate the relative vaccine efficacy (rVE), safety, reactogenicity, and immunogenicity of mRNA-...

Active, not recruiting
COVID-19
Biological: mRNA-1283.222
Biological: mRNA-1273.815

Phase 3

Moderna
Moderna

Pointe-Claire, Quebec, Canada and 217 other locations

The purpose of this study is to find out if immunization with IMM-101 will reduce the incidence of severe respiratory and COVID-19 ...

Active, not recruiting
Covid-19
Cancer
Other: Observation
Biological: IMM-101

Phase 3

Canadian Cancer Trials Group

Montreal, Quebec, Canada and 7 other locations

known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19.The aim of the Phase I/III study (Parent Study) will -...

Active, not recruiting
COVID-19, SARS-CoV-2
Biological: AZD3152 (Sub-study)
Biological: Placebo (Parent study Sentinel Safety Cohort)

Phase 2, Phase 3

AstraZeneca
AstraZeneca

Montreal, Quebec, Canada and 214 other locations

proteins of three coronaviruses: SARS-CoV-2 (the virus that causes COVID-19 disease), SARS-CoV-1 and MERS-CoV. The trivalent vaccin...

Active, not recruiting
COVID-19
Coronavirus Infections
Biological: VBI-2901a

Phase 1

VBI Vaccines

Pointe-Claire, Quebec, Canada and 6 other locations

The main goals of this study are to assess the immune response and safety of two different vaccines for first, second, third and fourth doses as well...

Active, not recruiting
COVID-19
Biological: Covifenz
Biological: mRNA-1273 SARS-CoV-2 vaccine

Phase 2

Canadian Immunization Research Network

Montréal, Quebec, Canada and 7 other locations

This Phase 2/3 study is a multi-portion design to confirm that the chosen formulation and dosing regimen of CoVLP has an acceptable immunogenicity an...

Active, not recruiting
SARS-CoV-2 Infection
Biological: Intramuscular vaccine
Drug: Intramuscular injection

Phase 2, Phase 3

Medicago

Pierrefonds, Quebec, Canada and 90 other locations

ESSOR is a double-blind, placebo-controlled study of the orally-administered antiviral and inflammation-controlling LAU-7b for the treatment of adult...

Active, not recruiting
Long COVID
Drug: LAU-7b for 3 cycles
Drug: LAU-7b for 1 cycle, then placebo

Phase 2, Phase 3

Laurent Pharmaceuticals

Montréal, Quebec, Canada and 4 other locations

The purpose of the Phase 2 CSEG101B2201 study is to confirm and to establish appropriate dosing and to evaluate the safety in pediatric participants...

Active, not recruiting
Sickle Cell Disease (SCD)
Drug: Crizanlizumab

Phase 2

Novartis
Novartis

Montreal, Quebec, Canada and 35 other locations

This is an international, open-label, stratified randomized controlled trial with Bayesian adaptive stopping rules to compare the effects of therapeu...

Enrolling
Community-acquired Pneumonia
Drug: Heparin

Phase 3

University of Manitoba

Montréal, Quebec, Canada and 65 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems